Literature DB >> 16978447

Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

Hilal A Lashuel1, Peter T Lansbury.   

Abstract

Protein fibrillization is implicated in the pathogenesis of most, if not all, age-associated neurodegenerative diseases, but the mechanism(s) by which it triggers neuronal death is unknown. Reductionist in vitro studies suggest that the amyloid protofibril may be the toxic species and that it may amplify itself by inhibiting proteasome-dependent protein degradation. Although its pathogenic target has not been identified, the properties of the protofibril suggest that neurons could be killed by unregulated membrane permeabilization, possibly by a type of protofibril referred to here as the 'amyloid pore'. The purpose of this review is to summarize the existing supportive circumstantial evidence and to stimulate further studies designed to test the validity of this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978447     DOI: 10.1017/S0033583506004422

Source DB:  PubMed          Journal:  Q Rev Biophys        ISSN: 0033-5835            Impact factor:   5.318


  140 in total

1.  Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.

Authors:  Jonathan A Fauerbach; Dmytro A Yushchenko; Sarah H Shahmoradian; Wah Chiu; Thomas M Jovin; Elizabeth A Jares-Erijman
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Microcin amyloid fibrils A are reservoir of toxic oligomeric species.

Authors:  Mohammad Shahnawaz; Claudio Soto
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

3.  Effects of hypericin on the structure and aggregation properties of β-amyloid peptides.

Authors:  Emilia Bramanti; Francesco Lenci; Antonella Sgarbossa
Journal:  Eur Biophys J       Date:  2010-05-15       Impact factor: 1.733

4.  A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins.

Authors:  Jampani Nageswara Rao; Christine C Jao; Balachandra G Hegde; Ralf Langen; Tobias S Ulmer
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

Review 5.  Applications of biological pores in nanomedicine, sensing, and nanoelectronics.

Authors:  Sheereen Majd; Erik C Yusko; Yazan N Billeh; Michael X Macrae; Jerry Yang; Michael Mayer
Journal:  Curr Opin Biotechnol       Date:  2010-06-18       Impact factor: 9.740

6.  The molecular basis of distinct aggregation pathways of islet amyloid polypeptide.

Authors:  Lei Wei; Ping Jiang; Weixin Xu; Hai Li; Hua Zhang; Liangyu Yan; Mary B Chan-Park; Xue-Wei Liu; Kai Tang; Yuguang Mu; Konstantin Pervushin
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

7.  Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.

Authors:  Rajeev K Chaudhary; Kinjal A Patel; Milan K Patel; Radha H Joshi; Ipsita Roy
Journal:  Mol Ther       Date:  2015-08-27       Impact factor: 11.454

8.  Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations.

Authors:  Sébastien Côté; Vincent Binette; Evgeniy S Salnikov; Burkhard Bechinger; Normand Mousseau
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

9.  A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

Authors:  James A Hebda; Ishu Saraogi; Mazin Magzoub; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2009-09-25

10.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.